BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 9380582)

  • 1. Nurses should monitor cutaneous toxicity in chemotherapy regimens with paclitaxel.
    Knobf MT; Staugaard C
    Oncol Nurs Forum; 1997 Sep; 24(8):1328. PubMed ID: 9380582
    [No Abstract]   [Full Text] [Related]  

  • 2. Limited cutaneous systemic sclerosis induced by paclitaxel in a patient with breast cancer.
    Kawakami T; Tsutsumi Y; Soma Y
    Arch Dermatol; 2009 Jan; 145(1):97-8. PubMed ID: 19153362
    [No Abstract]   [Full Text] [Related]  

  • 3. Paclitaxel-induced cutaneous lupus erythematosus in patients with serum anti-SSA/Ro antibody.
    Adachi A; Horikawa T
    J Dermatol; 2007 Jul; 34(7):473-6. PubMed ID: 17584326
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Subungal abcesses secondary to paclitaxel.
    Albares MP; Belinchón I; Pascual JC; Vergara G; Blanes M; Betlloch I
    Dermatol Online J; 2003 Aug; 9(3):16. PubMed ID: 12952763
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neoadjuvant chemotherapy with weekly paclitaxel in breast cancer patients may increase release of cancer cells into circulation by decreasing interstitial fluid pressure.
    Altundag O; Altundag K; Gundeslioglu O; Silay YS; Ersoy Y
    Med Hypotheses; 2006; 66(4):857-8. PubMed ID: 16039067
    [No Abstract]   [Full Text] [Related]  

  • 6. Case report: paclitaxel-induced myocardial ischemia.
    Soe MS; Berkman A; Mardelli TJ
    Md Med J; 1996 Jan; 45(1):41-3. PubMed ID: 8569460
    [No Abstract]   [Full Text] [Related]  

  • 7. Peripheral neuropathy in a woman with breast cancer.
    Cianfrocca M; Flatters SJ; Bennett GJ; McNicol E; Relias V; Carr D; Gillis TA
    J Pain; 2006 Jan; 7(1):2-10. PubMed ID: 16414547
    [No Abstract]   [Full Text] [Related]  

  • 8. Cardiac dysfunction in cancer patients receiving paclitaxel.
    Valdés Olmos RA; ten Bokkel Huinink WW; Hoefnagel CA
    Eur J Nucl Med; 1998 Apr; 25(4):446-7. PubMed ID: 9643974
    [No Abstract]   [Full Text] [Related]  

  • 9. [Safety evaluation of paclitaxel injection NK in adjuvant therapy for breast cancer].
    Takahara S; Yamamoto H; Tokushima Y; Shiba E
    Gan To Kagaku Ryoho; 2009 Nov; 36(11):1851-6. PubMed ID: 19920387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cystoid macular edema secondary to nab-paclitaxel therapy.
    Murphy CG; Walsh JB; Hudis CA; Lake D; Theodoulou M
    J Clin Oncol; 2010 Nov; 28(33):e684-7. PubMed ID: 20805460
    [No Abstract]   [Full Text] [Related]  

  • 11. [Taxol (paclitaxel) as second-line therapy in breast and ovarian cancer].
    Borovik R; Steiner M; Atad J; Sneiderman B; Rosenberg T; Palti S
    Harefuah; 1998 Apr; 134(8):605-8, 671. PubMed ID: 10911422
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Paclitaxel].
    Díaz M; Campanero MA
    Rev Med Univ Navarra; 1996; 40(3):43-51. PubMed ID: 9499826
    [No Abstract]   [Full Text] [Related]  

  • 13. Association between paclitaxel and necrotic pancreatitis.
    McMahon MA; Kearns G; McCaffrey J; Grogan L
    Ir Med J; 2006 Oct; 99(9):281. PubMed ID: 17144240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemotherapy-induced acral erythema sparing the palms.
    Housholder AL; Adams BB
    J Am Acad Dermatol; 2012 Sep; 67(3):e116-7. PubMed ID: 22890739
    [No Abstract]   [Full Text] [Related]  

  • 15. Paclitaxel-induced nail changes: possible role of its vehicle (Cremophor EL).
    Minutilli E; Izzo F; Natoli G; Psaila A; Di Filippo F; Terzoli E
    Eur J Dermatol; 2006; 16(6):693-4. PubMed ID: 17229616
    [No Abstract]   [Full Text] [Related]  

  • 16. Another reader shares experience with paclitaxel reactions.
    Wojtaszek C
    Oncol Nurs Forum; 2001 Apr; 28(3):446. PubMed ID: 11338753
    [No Abstract]   [Full Text] [Related]  

  • 17. Adverse effects of paclitaxel in patients with alcohol abuse histories.
    Henderson-Martin B
    Clin J Oncol Nurs; 2000; 4(1):11-4. PubMed ID: 10865578
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nail alterations secondary to pactitaxel [corrected] therapy.
    Almagro M; Pozo JD; Garcia J; Vasquez A; Fonseca E
    Eur J Dermatol; 2000 Mar; 10(2):146-7. PubMed ID: 10694317
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Invited commentary.
    Campbell KL; McNeely ML
    Phys Ther; 2010 Nov; 90(11):1657-9; author reply 1659. PubMed ID: 21041184
    [No Abstract]   [Full Text] [Related]  

  • 20. Reversible paclitaxel-induced vocal cord paralysis with later recall with vinorelbine.
    Choi BS; Robins HI
    Cancer Chemother Pharmacol; 2008 Feb; 61(2):345-6. PubMed ID: 18026678
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.